NCT00030563View on ClinicalTrials.gov

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2005

Conditions
Colorectal CancerMetastatic Cancer
Interventions
DRUG

irinotecan hydrochloride

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

PROCEDURE

radiofrequency ablation

Trial Locations (3)

98195

University of Washington School of Medicine, Seattle

44106-5065

Ireland Cancer Center, Cleveland

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT00030563 - Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver | Biotech Hunter | Biotech Hunter